0
Views
1
CrossRef citations to date
0
Altmetric
Invited communication

The do’s and don’ts of arginine supplementation

Pages 25-28 | Published online: 31 May 2016

References

  • Pharmaconutrition: a new emerging paradigm. Jones NE, Heyland DK. 2008, Current Opin Gastroenterol, Vol. 24, pp. 215–222.
  • Use of Exogenous Arginine in Multiple Organ Dysfunction Syndrome and Sepsis. Barbul A, Uliyargoli A. 9 (Suppl), s.l. : Lippincott Williams & Wilkins, 2007, Critical Care Medicine, Vol. 35, pp. S564 – S567.
  • Arginine: Biochemistry, Physiology and Therapeutic Implications. Barbul A. 1986, Journal of Parenteral and Enteral Nutrition, Vol. 10, pp. 227–238.
  • Arginine Metabolism: Nitric Oxide and Beyond. Wu G, Morris SM Jr. 1998, Biochem J, Vol. 336, pp. 1–17.
  • Agmatine: At the Crossroads of Arginine Pathways. Satriano J. 2003, Ann NY Acad Sci , Vol. 1009, pp. 34–43.
  • Macrophage Syntehsis of Nitrite, Nitrate and N-nitrosamines: precursors and role of the respiratory burst. Iyengar R, Stuehr DJ, MArletta MA. 1987, Proc. Natl Acad. Sci, Vol. 84, pp. 6369–6373.
  • Vascular endothelial cells synthesis of nitric oxide from L-argenine. Palmer RMJ , Ashton DS, Moncada S. Nature, Vol. 333, pp. 664–666.
  • Arginine is a precursor of Endothelial derived Nitric Oxide. Schmidt HHHW, Nau H, Wittfoht W, Gerlach J, Prescher KE et al. European Journal of Pharmacology, Vol. 154, pp. 213 – 216.
  • Nitric Oxide accounts for the biological activity of endothelium derived relaxing factor. Palmer RMJ, Ferrige AG, Moncada S. Nature, Vol. 327, pp. 524–526.
  • An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Radomski MW, Palmer RMJ, Moncada S. Proc. Natl. Acad. Sci, Vol. 87, pp. 5193–5197.
  • Nitric Oxide: an endogenous modulator of leukocyte adhesion. Kubes P, Suzuki M, Granger DN. Proc. Natl. Acad. Sci., Vol. 88, pp. 4651–4655.
  • Nitric Oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth mucscle cells. Garg UC, Hassid A. 1989, J Clin. Invest., Vol. 83, pp. 1774–1777.
  • Nitric oxide modulates the expression of monocyte chemoattractant protein-1 in cultured human endothelial cells. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Circ Res, Vol. 76, pp. 980–86.
  • The Clinical Pharmacology of L-Arginine. Boger RH, Bode-Boger SM. 2001, Annual Review of Pharmacology and Toxicology, Vol. 1, pp. 79–99.
  • Characterisation of three inhibitors of endothelial nitric oxide synthase in vitri and in vivo. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. 1990, British Journal of Pharmacology, Vol. 101, pp. 746–752.
  • Native low density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Pritchard KA, Groszek L, Smalley DM, Sessa WC, Wu M et al. Circ. Res., Vol. 77, pp. 510–518.
  • Correction of Endothelial Dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Drexler H, Zeiher AM, Meinzer K, Just H. 1991, Lancet, Vol. 338, pp. 1546–1550.
  • L-arginine improves endothelium-dependant vasodilation in hypercholesterolemic humans. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. 1992, J. Clin. Invest., Vol. 90, pp. 1248–1253.
  • Modulation of Coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Zeiher AM, Drexler H, Wollschlager H, Just H. 1991, Circulation, Vol. 83, pp. 391–401.
  • Restoring vascular NO formation by L-arginine improves the sypmtoms of intermittent claudication in patients with peripheral arterial occlusive disease. Boger RH, Bode-Boger SM, Thiele W, Creutzig A, Alexander K, Frohlich JC. Journal of American College of Cardiology, Vol. 32, pp. 1336–1344.
  • Dose related effect of intravenous L-arginine on muscular blood flowof the calf in patients with peripheral vascular disease. Schellong SM, Boger RH, Burchert W, Bode-Boger SM, Galland A et al. 1997, Clin. Sci, Vol. 93, pp. 159–165.
  • Long term L-arginine supplementation improves small vessel coronary artery endothelial funtion in humans. Lerman A, Burnett JC, Higano ST, McKinely LJ, Holmes DR. Circulation, Vol. 97, pp. 2123–2128.
  • Effect of Supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. 1997, American Journal of Cardiology, Vol. 80, pp. 331–333.
  • Randomised, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Rector TS, Bank AL, Mullen KA, Tschumperlin LK, Sih R et al. 1996, Circulation, Vol. 93, pp. 2135–2141.
  • Acute effect of nitric oxide on Raynaud’s phenomenon in scleroderma. Freedman GR, Girgis R, Mayes MD. 1999, Lancet, Vol. 354, p. 739.
  • Plasma amino acids as predictors of the severity and outcome of sepsis. Freund H, Atamian S, Holroyde J et al. 1979, Ann. Surg., Vol. 190, pp. 571–576.
  • Amino Acid Kinetics in patients with sepsis. Druml W, Heinzel G, Kleinberger G. 2001, Americal Journal of Clinical Nutrition, Vol. 73, pp. 908–913.
  • Low Plasma Agrinine concentration in Septic Patients is related to diminished de novo arginine production from Citrulline. Luiking YC, Steens L, Poeze M et al. Supplement, 2003, Clinical Nutrition, Vol. 22, p. S26.
  • Plasma Arginine Correlations in trauma and Sepsis. Chiarla C, Giovannini I, Siegel JH. 2006, Amino Acids, Vol. 30, pp. 81–86.
  • L–agrinine infusion does not deteriorate the haemodynamic condition in patients with severe sepsis. Luiking YC, Poeze M, Hendrikx M et al. 2005, Clin Nutr., Vol. 24, pp. 612–613.
  • Metabolic Support in Sepsis and Multiple Organ Failure: More Questions than Answers. Vincent JL. 9 (Suppl), 2007, Critical Care Medicine, Vol. 35, pp. S436–S440.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.